Loading...
Vext Science, Inc.
VEXT.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.21
CA$0.00(0.00%)
Vext Science, Inc. (VEXT.CN) Financial Performance & Income Statement Overview
Analyze Vext Science, Inc. (VEXT.CN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
3.40%
↑ 3.40%
Operating Income Growth
-520.38%
↓ 520.38%
Net Income Growth
-610.07%
↓ 610.07%
Operating Cash Flow Growth
-25.68%
↓ 25.68%
Operating Margin
-19.88%
↓ 19.88%
Gross Margin
25.37%
↑ 25.37%
Net Profit Margin
-49.62%
↓ 49.62%
ROE
-24.29%
↓ 24.29%
ROIC
-6.78%
↓ 6.78%
Vext Science, Inc. (VEXT.CN) Income Statement & Financial Overview
Analyze Vext Science, Inc.’s VEXT.CN earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.19M | $8.99M | $8.43M | $8.35M |
| Cost of Revenue | $8.06M | $5.02M | $6.87M | $11.01M |
| Gross Profit | $2.14M | $3.97M | $1.55M | -$2.66M |
| Gross Profit Ratio | $0.21 | $0.44 | $0.18 | -$0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.84M | $3.01M | $3.01M | $1.33M |
| Operating Expenses | $5.03M | $5.26M | $1.55M | $1.33M |
| Total Costs & Expenses | $13.09M | $10.28M | $9.89M | $12.35M |
| Interest Income | $40005.00 | $40603.00 | $49012.00 | $89452.00 |
| Interest Expense | $1.32M | $867201.00 | $850855.00 | $890132.00 |
| Depreciation & Amortization | $3.76M | $3.83M | $3.89M | $3.57M |
| EBITDA | -$2.008M | $1.96M | $219136.00 | -$2.02M |
| EBITDA Ratio | -$0.20 | $0.22 | $0.03 | -$0.24 |
| Operating Income | -$2.89M | -$1.29M | -$1.46M | -$3.99M |
| Operating Income Ratio | -$0.28 | -$0.14 | -$0.17 | -$0.48 |
| Other Income/Expenses (Net) | -$4.30M | -$1.44M | -$3.06M | -$3.44M |
| Income Before Tax | -$7.20M | -$2.74M | -$4.52M | -$6.48M |
| Income Before Tax Ratio | -$0.71 | -$0.30 | -$0.54 | -$0.78 |
| Income Tax Expense | $2.02M | -$238844.00 | -$127244.00 | -$339000.00 |
| Net Income | -$9.21M | -$2.50M | -$4.39M | -$6.31M |
| Net Income Ratio | -$0.90 | -$0.28 | -$0.52 | -$0.75 |
| EPS | -$0.04 | -$0.01 | -$0.02 | -$0.03 |
| Diluted EPS | -$0.04 | -$0.01 | -$0.02 | -$0.03 |
| Weighted Avg Shares Outstanding | $180.17M | $245.55M | $245.45M | $225.13M |
| Weighted Avg Shares Outstanding (Diluted) | $180.17M | $248.66M | $245.45M | $225.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan